Srikanth Priya, Young-Pearse Tracy L
Center for Neurologic Diseases, Brigham and Women's Hospital , Boston, Massachusetts , USA.
J Neurogenet. 2014 Mar-Jun;28(1-2):5-29. doi: 10.3109/01677063.2014.881358. Epub 2014 Mar 17.
Seven years have passed since the initial report of the generation of induced pluripotent stem cells (iPSCs) from adult human somatic cells, and in the intervening time the field of neuroscience has developed numerous disease models using this technology. Here, we review progress in the field and describe both the advantages and potential pitfalls of modeling neurodegenerative and neurodevelopmental diseases using this technology. We include tables with information on neural differentiation protocols and studies that developed human iPSC lines to model neurological diseases. We also discuss how one can: investigate effects of genetic mutations with iPSCs, examine cell fate-specific phenotypes, best determine the specificity of a phenotype, and bring in vivo relevance to this in vitro technique.
自首次报道从成人人类体细胞生成诱导多能干细胞(iPSC)以来,已经过去了七年,在此期间,神经科学领域利用这项技术开发了众多疾病模型。在这里,我们回顾该领域的进展,并描述使用这项技术对神经退行性疾病和神经发育疾病进行建模的优点和潜在缺陷。我们提供了包含神经分化方案信息的表格,以及开发人类iPSC系以模拟神经疾病的研究。我们还讨论了如何利用iPSC研究基因突变的影响、检查细胞命运特异性表型、最佳确定表型的特异性,以及使这项体外技术具有体内相关性。